Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline

Jennifer Y. Wo, Christopher J. Anker, Jonathan B. Ashman, Nishin A. Bhadkamkar, Lisa Bradfield, Daniel T. Chang, Jennifer Dorth, Julio Garcia-Aguilar, David Goff, Dustin Jacqmin, Patrick Kelly, Neil B. Newman, Jeffrey Olsen, Ann C. Raldow, Erika Ruiz-Garcia, Karyn B. Stitzenberg, Charles R. Thomas, Q. Jackie Wu, Prajnan Das

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Purpose: This guideline reviews the evidence and provides recommendations for the indications and appropriate technique and dose of neoadjuvant radiation therapy (RT) in the treatment of localized rectal cancer. Methods: The American Society for Radiation Oncology convened a task force to address 4 key questions focused on the use of RT in preoperative management of operable rectal cancer. These questions included the indications for neoadjuvant RT, identification of appropriate neoadjuvant regimens, indications for consideration of a nonoperative or local excision approach after chemoradiation, and appropriate treatment volumes and techniques. Recommendations were based on a systematic literature review and created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. Results: Neoadjuvant RT is recommended for patients with stage II-III rectal cancer, with either conventional fractionation with concurrent 5-FU or capecitabine or short-course RT. RT should be performed preoperatively rather than postoperatively. Omission of preoperative RT is conditionally recommended in selected patients with lower risk of locoregional recurrence. Addition of chemotherapy before or after chemoradiation or after short-course RT is conditionally recommended. Nonoperative management is conditionally recommended if a clinical complete response is achieved after neoadjuvant treatment in selected patients. Inclusion of the rectum and mesorectal, presacral, internal iliac, and obturator nodes in the clinical treatment volume is recommended. In addition, inclusion of external iliac nodes is conditionally recommended in patients with tumors invading an anterior organ or structure, and inclusion of inguinal and external iliac nodes is conditionally recommended in patients with tumors involving the anal canal. Conclusions: Based on currently published data, the American Society for Radiation Oncology task force has proposed evidence-based recommendations regarding the use of RT for rectal cancer. Future studies will look to further personalize treatment recommendations to optimize treatment outcomes and quality of life.

Original languageEnglish (US)
Pages (from-to)13-25
Number of pages13
JournalPractical Radiation Oncology
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2021

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline'. Together they form a unique fingerprint.

Cite this